Physician profile
Thomas W Huff
NPI 1720252810
$95,166.35
in general payments reported to CMS, 2019-2025
7 companies · $20K in 2025
The $20K reported for 2025 was more than what 82% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $4,296 · 2021: $3,284 · 2022: $16.80 · 2023: $1,350 · 2024: $629 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $4,110 · Food and Beverage: $2,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,600.00 |
| Travel and Lodging | $4,109.77 |
| Food and Beverage | $2,179.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $63,547.79 | 2019-2025 | Real Intelligence, Journey II, Polarstem |
| Encore Medical, Lp | $19,064.03 | 2023-2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $10,681.95 | 2019-2020 | |
| Exactech, INC. | $1,547.64 | 2023-2025 | |
| Next Science LLC | $222.61 | 2023 | Blastx, Xperience, Surgx |
| Medshape, INC. | $81.42 | 2024 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Stryker Corporation | $20.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.